BRAIN Biotech AG ESG | Targets, Opportunities and Key Points with IR episode artwork

EPISODE · Jun 21, 2022 · 5 MIN

BRAIN Biotech AG ESG | Targets, Opportunities and Key Points with IR

from Investor Insights from CEOs & CFOs | seat11a · host seat11a.com

BRAIN Biotech AG ESG: Key Takeaways Welcome to Our Video Feature Welcome to our video featuring Michael Schneiders, the Head of Investor Relations at Brain Biotech AG. Join him as he presents on ESG (Environmental, Social, and Governance) and guides you through five key points of ESG+, targets for 2032/2050, and the opportunities that ESG presents. ESG Presentation by Michael Schneiders Other videos: ⁠Elevator Pitch⁠ ⁠Company Presentation⁠ ⁠Deep Dive Presentation⁠ ⁠Financial Results Presentation⁠ ⁠ESG Presentation⁠ T&C: This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on ⁠www.seat11a.com/legal⁠ and ⁠www.seat11a.com/imprint⁠.

Episode metadata supplied by the publisher feed · Published Jun 21, 2022

Embed this episode

Ready to play

BRAIN Biotech AG ESG | Targets, Opportunities and Key Points with IR

0:00 5:40

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Investor Insights from CEOs & CFOs | seat11a?

This episode is 5 minutes long.

When was this Investor Insights from CEOs & CFOs | seat11a episode published?

This episode was published on June 21, 2022.

Can I download this Investor Insights from CEOs & CFOs | seat11a episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!